Avoid unnecessary biopsies, surgeries, and treatment for prostate cancer
One in eight men will be diagnosed with prostate cancer during their lifetime. Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland, and is elevated in most men who have prostate cancer.
However, the PSA can also very commonly be elevated in men who do not have cancer or have low-risk cancer that requires an active surveillance plan. As a result, unnecessary biopsies, surgeries, and treatments may be done without knowing the true risk of cancer to the patient.
A better solution? A more accurate test that could distinguish between patients who have an early, aggressive cancer and should proceed to biopsy, and those with a false positive PSA test who could safely forego biopsy.
MyProstateScore is a urine test that patients with an elevated PSA can get with their urologist. Unlike PSA, which can be elevated for several reasons, MyProstateScore measures two components of urine that are associated specifically with prostate cancer.
